Today, I want to give you a quick update on each of these. But before we begin, it’s time to close out the one position that isn’t doing so well … our bearish play on Zillow Group (Nasdaq: Z).
U.S. companies are now reporting first-quarter (January, February and March) earnings. Realize though, the nationwide lockdown of the U.S. economy is just barely factored into these numbers.
The broader health care sector’s outperformance is largely being driven by biotech stocks. Since we made a bullish play on the SPDR Biotech ETF (NYSE: XBI) at last Wednesday’s open, shares of XBI have gained 8.8% … more than any other major U.S. industry group ETF I track.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!